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When Saccharomyces cerevisiae a cells bind a-factor pheromone, the ligand is internalized and its binding
sites are lost from the cell surface in a time-, energy-, and temperature-dependent manner. This report presents
direct evidence for a-factor-induced internalization of cell surface receptors. First, membrane fractionation on
Renografin density gradients indicated that the a-factor receptors were predominantly found in the plasma
membrane peak before a-factor treatment and then appeared in membranes of lesser buoyant density after
a-factor exposure. Second, receptors were susceptible to cleavage by extracellular proteases before a-factor
treatment and then became resistant to proteolysis after exposure to pheromone, consistent with the transit of
receptors from the cell surface to an internal compartment. The median transit time in both assays was
approximately 8 min. The ultimate target of the internalized receptors was identified as the vacuole, since the
membranes containing internalized receptors cofractionated with vacuolar membranes, since the turnover of
receptors was stimulated by a-factor exposure, and since receptor degradation was blocked in a pep4 mutant
that is deficient for vacuolar proteases. The carboxy-terminal domain of the receptor that is required for ligand
internalization was also found to be essential for endocytosis of the receptor. A receptor mutant, ste2-L236H,
which is defective for pheromone response but capable of ligand internalization, was found to be proficient for
receptor endocytosis. Hence, separate structural features of the receptor appear to specify its signal transduction
and internalization activities.
For Saccharomyces cerevisiae, the induction of mating-spe-
cific processes is mediated by the exchange of the peptide
mating factors that are produced by the two haploid cell types,
a and a cells (reviewed in references 39 and 57). a cells secrete
the pheromone a-factor, whereas a cells secrete a-factor
pheromone. Receptors specific for these pheromones are
found on the surface of cells of the opposite cell type, i.e., the
a-factor receptors, encoded by the STE2 gene, are found on a
cells (28), whereas the a-factor receptors, encoded by STE3,
are found on a cells (24). The binding of either pheromone to
its receptor initiates a signal transduction pathway that in-
cludes the action of a heterotrimeric G protein (21, 42, 62) and
a protein kinase cascade related to the mitogen-activated
protein kinase cascade found in mammalian systems (44). This
signal facilitates mating by blocking cell division at G1, stimu-
lating the transcription of several genes that encode mating-
specific activities, and inducing morphological changes of the
cells. In the absence of mating, the haploid cells adapt to the
action of a-factor by degrading the pheromone extracellularly
(11, 15) and by regulating postreceptor events in the response
pathway (4, 13, 20, 34, 41, 47).
DNA sequence analysis of the STE2 and STE3 genes (8, 24,
43) as well as topological studies of the gene products (10, 18)
suggest that both receptors contain seven transmembrane
domains, an extracellular amino terminus, and a carboxy
terminus exposed to the cytoplasm. This structure is charac-
teristic of G-protein-coupled receptors such as rhodopsin and
the P-adrenergic receptors (22). Although the a-factor and
a-factor receptors activate the same signalling pathway (3),
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presumably by interacting with a common G protein (6, 29),
they share no obvious sequence homology. Mutational studies
of the a-factor receptor (17, 61) and other receptors with a
similar structure (23, 32) implicate the third cytoplasmic loop
in the coupling of these receptors to their respective G
proteins. Other mutational analyses indicate that the carboxy-
terminal cytoplasmic domain of the pheromone receptor is
important for receptor down regulation, pheromone internal-
ization, adaptation to the pheromone-induced signal, and
pheromone-induced morphological changes (33, 34, 47, 49).
A large body of experimental evidence suggests that phero-
mones are internalized by receptor-mediated endocytosis. Ra-
dioactive at-factor becomes associated irreversibly with a cells
in an energy- and receptor-dependent manner (14, 30). This
association is accompanied by a disappearance of ligand-
binding sites from the cell surface (30). Clathrin, which plays a
major role in receptor-mediated endocytosis in mammalian
cells, has recently been shown to facilitate the internalization
of a-factor (58). Following internalization, the pheromone
appears to be translocated to the vacuole via vesicular inter-
mediates (54), which may represent early and late endosomes
(55). Although there is no direct evidence that the ao-factor
receptor leaves the cell surface upon binding pheromone,
a-factor receptors have been shown to pass from the plasma
membrane to the vacuole, and this process is accelerated when
at cells are treated with a-factor (19). There is as yet no direct
evidence for the internalization of the a-factor ligand.
We sought physical evidence for the ligand-induced endocy-
tosis of the a-factor receptor. Three independent criteria were
used to establish the movement of a-factor receptors from the
plasma membrane to internal compartments of the cell. First,
Renografin density gradient centrifugation was used to frac-
tionate the cellular membranes, allowing us to follow the
ligand-induced exit of the receptor from the plasma membrane
upon at-factor exposure. Second, protease susceptibility assays
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showed that the receptor became resistant to external protease
upon pheromone addition. Third, the destination for the
internalized receptors was identified as the vacuole by exam-
ining the half-life of the receptor in the presence and absence
of vacuolar proteases. The relationship between endocytosis
and signal transduction was explored by using receptor mu-
tants exhibiting defects in one of these functions.
MATERIALS AND METHODS
Strains and plasmids. All strains are congenic to strain
381G (27). The genotype of strain DJ211-5-3 is AATa ctyl
barl-] ade2-1 his4-580 leu2 lys2 trpl tyrl ura3 SUP4-3. Strain
DJ213-7-3 is MATa cryl barl-] ste2-1O::LEU2 ade2-1 his4-580
leu2 lys2 trpl tyrl ura3 SUP4-3. Strain DJ900-A, which contains
the pep4::URA3 mutation, is a derivative of strain DJ211-5-3. It
was constructed by a single-step gene replacement procedure
(52) in which strain DJ211-5-3 was transformed with the
XhoI-EcoRI fragment from plasmid pTS15 (51) carrying
pep4::URA3. The presence of the pep4::URA3 allele was con-
firmed by PCR analysis. Yeast centromere plasmid pJBKO08,
which contains STE2 and URA3, was described previously (34).
Plasmid pDJ252 was constructed by subcloning the ste2-T326
allele from pJBKO23 (34) into the yeast integrating vector
pDJ251, which contains the URA3 gene. Strain DJ903-A-1
containing ste2-T326 was derived from strain DJ211-5-3 by the
two-step gene replacement method (7) with plasmid pDJ252;
the presence of the ste2-T326 allele was confirmed by Southern
blot analysis. Strains DJ900-B and DJ903-C, both of which
contain the mfcx] ::URA3 allele, were constructed by transform-
ing strains DJ211-5-3 and DJ903-A-1, respectively, with the
EcoRI-SalI fragment from plasmid pBH3 (36); PCR analysis
was used to confirm the presence of the mfa1::URA3 allele.
Antisera and reagents. Rabbit polyclonal antisera used in
immunoblotting procedures were specific for the amino-termi-
nal or the carboxy-terminal portion of the al-factor receptor
(34); an integral membrane subunit of the vacuolar ATPase,
Vphl (38); a marker of the endoplasmic reticulum, Kar2 (53);
the Golgi apparatus lumenal guanosine diphosphatase (GD-
Pase) (1); or the cytosolic marker phosphoglycerate kinase.
Mouse monoclonal antibodies C56 (2) were shown to be
specific for the plasma membrane ATPase, Pmal, since they
could specifically bind a Pmal--lactamase fusion protein
(obtained from D. J. Tipper, University of Massachusetts,
Worcester). Peroxidase-conjugated secondary antibodies, goat
anti-mouse and goat anti-rabbit, were from Kirkegaard and
Perry Laboratories, Inc., Gaithersburg, Md. Renografin-76
(76% Renografin) is a product of Squibb Diagnostics, New
Brunswick, N.J. Synthetic a-factor was purchased from Sigma
Chemical Co., St. Louis, Mo. 35S-labelled a-factor (approxi-
mately 50 Ci/mmol) was prepared by culturing strain FY70
(MA4Ta leu2) containing plasmid pDA6300 (5) in low-sulfate
minimal medium with carrier-free [35S]sulfuric acid, and sub-
sequent Bio-Rex 70 chromatography (16) of the resulting
culture supernatant.
Membrane fractionation. Cells were cultured overnight at
30°C in YM-1 medium (26) to 107 cells per ml. Cycloheximide
was added to 10 ,ug/ml. After 5 min, ao-factor was added to
10-8 M. At the times indicated, samples containing 5 x 108
cells were removed to prechilled flasks and poisoned by adding
NaN3 and KF to 10 mM. Cells were collected by centrifuga-
tion, washed with 10 ml of ice-cold sorbitol buffer (50 mM Tris
[pH 7.6], 0.8 M sorbitol, 10 mM NaN3, 10 mM KF), washed
twice with 1 ml of sorbitol buffer, once with 1 ml of sorbitol
buffer containing 100 ,ug of phenylmethylsulfonyl fluoride
(PMSF) and 2 jig of pepstatin A and once with 1 ml of TE (50
mM Tris [pH 7.5], 1 mM EDTA) containing the same protease
inhibitors. The cells were suspended in 0.5 ml ofTE containing
protease inhibitors and then lysed by mechanical disruption
with glass beads. Unbroken cells were removed from the lysate
by centrifugation for 5 min at 330 x g in a 1.5-ml microcen-
trifuge tube in a Sorvall SS-34 rotor. Of the supernatant, 0.5 ml
was combined with 0.5 ml of Renografin-76 and placed in the
bottom of a centrifuge tube. Flotation gradients were prepared
by successively layering 1 ml of 34, 30, 26, and 22% Renografin
solutions that had been prepared by diluting Renografin-76
with TE. The gradients were centrifuged in an SW50.1 rotor at
150,000 x g for 20 h at 4°C. Fractions (350 pl) were collected
from the top of each gradient. Samples were diluted 1:3 with
sample buffer (1 g of urea dissolved in 1 ml of 17.5 mM
Tris-HCl [pH 6.8] containing 1.75% sodium dodecyl sulfate
[SDS], 1% ,-mercaptoethanol, bromophenol blue), heated at
37°C for 10 min, and loaded on 10% polyacrylamide gels for
SDS electrophoretic analysis (37). Proteins were transferred to
an Immobilon membrane (Millipore Corp, Bedford, Mass.).
The membrane was probed with antiserum, and the immune
complexes were detected by using the ECL chemiluminescence
detection system (Amersham Life Science, Arlington Heights,
Ill.). The resulting signal was quantified by using a model
SLR-lD/2D Zeineh soft laser scanning densitometer. The
density of the fractions was estimated from the refractive index
(9).
Determination of receptor half-life. Strains DJ211-5-3 and
DJ900-A were grown to mid-log phase and treated with
cycloheximide and pheromone (as indicated), and lysates were
prepared as for membrane fractionation. After the 330 x g
centrifugation step, the protein content of the supernatant was
determined by the bicinchoninic acid assay (Pierce, Rockford,
Ill.). Samples were diluted to 0.2 mg of protein per ml with
sample buffer, heated at 37°C for 10 min, and analyzed by the
electrophoretic and immunoblotting methods detailed above.
Protease sensitivity assays. Cells were grown to 107 cells per
ml in YM-1 medium at 30°C. When present, cycloheximide was
added to 10 pug/ml. The culture was divided into seven 20-ml
cultures. at-Factor (108 M final concentration) was added to
the cultures at staggered intervals so as to give different
durations of at-factor exposure and identical durations (20
min) of cycloheximide exposure. After pheromone treatment,
the cultures were chilled rapidly and NaN3 and KF were added
to 10 mM. The cells were collected by centrifugation, washed
with 10 ml of sorbitol buffer, and suspended in 1 ml of sorbitol
buffer. Each sample was divided into two 500-pA aliquots. After
centrifugation, one cell pellet was suspended in 150 pA of
sorbitol buffer and the other was suspended in 150 pl of
sorbitol buffer containing 750 ,ug of chymotrypsin A4 (Boehr-
inger Mannheim, Indianapolis, Ind.). These suspensions were
incubated with agitation at 30°C for 16 h. Proteolysis was
stopped by adding PMSF and N-tosyl-L-phenylalanine chlo-
romethyl ketone (TPCK) to 100 ,ug/ml. The cells were col-
lected, washed three times with sorbitol buffer containing
PMSF and TPCK, and then suspended in 150 ,ul of sample
buffer lacking P-mercaptoethanol and bromophenol blue and
lysed by mechanical disruption with glass beads. Lysates were
transferred to fresh tubes and heated at 37°C for 10 min, and
particulate matter was removed by centrifugation. The protein
concentration of the cleared lysates was determined with
bicinchoninic acid method and adjusted to 1 mg of protein per
ml with sample buffer (containing 1-mercaptoethanol) and
then heated to 37°C for 10 min. The proteins were resolved
electrophoretically and analyzed by immunoblotting as for
membrane fractionation.
Isolation of the ste2-L236H mutant. Plasmid pJBKO08 (34)
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containing the STE2 gene was subjected to hydroxylamine
mutagenesis (50) and used for the transformation of strain
DJ213-7-3. A total of 800 isolates were screened for growth on
minimal medium containing 2 x 10-8 M a-factor. The 65
a-factor-resistant isolates were tested for pheromone-binding
activity (30). Only one mutant retained the ability to bind
pheromone to the same extent as wild-type cells. The site of
the mutation was identified by subcloning various restriction
fragments into an otherwise wild-type copy of the STE2 gene
contained in plasmid pDJ251. The 274-bpAatll-ClaI fragment
that conferred the mutant phenotype was sequenced by using
the Sequenase kit (United States Biochemicals, Cleveland,
Ohio) and a double-stranded template. Two mutations were
found-a G-to-A transition at position 615 and a T-to-A
transversion at position 706. The Altered Sites in vitro Mu-
tagenesis System (Promega, Madison, Wis.) was used to create
a single T-to-A mutation at position 706 in the STE2 gene. The
presence of the mutation was confirmed by DNA sequencing,
and the AatII-ClaI fragment was subcloned into plasmid
pDJ251. Two-step gene replacement was used to replace the
chromosomal copy of STE2 in strain DJ211-5-3 with the
mutant gene, creating strain DJ901-A-1. The presence of the
mutant allele, which carries a unique NcoI restriction site, was
confirmed by PCR analysis followed by restriction digestion.
Mutant cells containing the single-base-pair substitution (des-
ignated ste2-L236H) exhibited a pheromone response pheno-
type that was indistinguishable from that of the original isolate.
Pheromone response assays. a-Factor halo assays were
conducted by moistening sterile filter disks (0.64-cm diameter)
with 20 [lI of various dilutions of a-factor (1 X 10-6 to 5 x
10-' M). The disks were then placed onto yeast extract-
peptone-dextrose YEPD solid medium that had been spread
with 5 x 106 cells of the strain to be tested. The size and clarity
of the zones of growth inhibition (haloes) were noted after 16,
24, and 48 h at 30°C, and the diameters of the zones were
measured after 48 h. Agglutination was assayed by the method
of Hartwell (27). The time course and dose response for arrest
of cell division in the presence of pheromone was determined
by the method of Moore (40). The strains used in this work
were barl mutants defective for a-factor destruction, which
obviated the need to work at low cell concentrations (30).
Cultures of strain DJ211-5-3 (A Ta bar] STE2) and strain
DJ901-A-1 (MA Ta barl ste2-L236H) growing exponentially in
YM-1 medium at 30°C were diluted to 5 x 10' cells per ml, and
a-factor was added to between 5 x 10`1 and 1 X 10-8 M.
Samples were removed periodically, fixed with formaldehyde
(3.7%), and sonicated lightly to disperse cell clumps. At least
200 cells from each time point were examined by phase-
contrast microscopy, and the number of budded and unbudded
cells was noted. The untreated control cultures gave roughly
40% unbudded cells, whereas maximally induced Ste' cultures
reached unbudded levels of nearly 100%.
RESULTS
Previous studies have used indirect techniques to monitor
the ligand-induced movement of a-factor receptors from the
cell surface to internal compartments of the cell. When a cells
are exposed to a-factor, the pheromone-binding sites disap-
pear from the cell surface in a time- and energy-dependent
manner with a concomitant internalization of the ligand (30).
Furthermore, a-factor receptors are periodically exposed to
internal compartments, since the basal rate of receptor turn-
over is dependent on vacuolar proteases (19). In this study, we
have used antibodies to monitor directly the movement and
degradation of receptor protein. We provide three lines of
evidence for ligand-induced endocytosis of a-factor receptors.
Membrane fractionation experiments demonstrated that re-
ceptors exit the plasma membrane and appear in membranes
of lighter buoyant density. Protease sensitivity assays show a
reduction in the susceptibility of receptors to extracellular
proteolysis upon pheromone addition. The destination of the
endocytosed receptors was inferred by comparing the half-lives
of the receptors in strains containing or lacking vacuolar
proteases.
Membrane fractionation. Centrifugation in Renografin den-
sity gradients was used to resolve the plasma membrane from
the other membranes of the cell. Previous workers (60) have
shown that the major plasma membrane species from S.
cerevisiae bands at a buoyant density of 1.17 g/ml in Renografin
gradients. We found that membranes carrying the plasma
membrane ATPase band at a similar density of 1.18 g/ml and
are clearly resolved from membranes containing a vacuolar
ATPase subunit, Vphl (38), which were distributed from a
buoyant density of 1.09 to 1.15 g/ml (Fig. 1A). Under the
conditions used, markers for the endoplasmic reticulum (Kar2)
and the Golgi apparatus (GDPase) were also separated from
the plasma membrane marker, but they were not resolved from
the vacuolar membrane marker (data not shown). Figure 1B
shows the buoyant density profiles obtained for the membranes
that contain the a-factor receptor after the cells had been
exposed to at-factor for various periods of time. A growing
culture of a cells was treated with cycloheximide to block new
protein synthesis, and a saturating concentration of a-factor
was added at time zero. As expected for a cell surface protein,
essentially all of the receptor was initially found in a peak
corresponding to the density of the plasma membrane. As time
progressed, the receptor protein gradually disappeared from
these fractions and accumulated in fractions of lighter buoyant
density that coincided with the vacuolar ATPase. By 20 min,
essentially all of the receptor was in these fractions of lighter
density. The positions of the marker proteins within the
gradient did not change with the addition of a-factor (data not
shown). Receptors from control cultures that received cyclo-
heximide and no a-factor did not show this shift in density (not
shown), indicating that cycloheximide did not cause the redis-
tribution of receptors. Moreover, a similar density shift was
obtained with cultures that had been treated with a-factor for
12 min in the absence of cycloheximide (not shown), indicating
that for this shorter time course the receptors disappeared
from the plasma membrane faster than they were replaced by
new synthesis. This result parallels our earlier finding that
a-factor exposure causes initial down regulation of the cell
surface pheromone-binding sites which is followed by a period
of reaccumulation (30).
By comparing the relative amounts of receptor protein in the
plasma membrane and the vacuolar membrane fractions, we
were able to estimate the time required for the transit of
receptors between the plasma membrane and the internal
compartments of the cell. Figure 1C shows that with increasing
time after pheromone addition an increasing proportion of the
receptor left the plasma membrane fractions and appeared in
the fractions of lesser density. After an 8-min exposure to
ax-factor, equal amounts of receptor protein were partitioned
between the plasma membrane and vacuolar fractions. We
were concerned that this period may be an underestimate of
the actual transit time, since the degradation of receptors was
likely to be more rapid in the vacuolar compartment than in
the plasma membrane. However, as described below, the
relative degradation rates of the two receptor species does not
significantly affect the apparent transit time, since very few
receptors, regardless of location, have been degraded during
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FIG. 1. Membrane fractionation and localization of a-factor recep-
tors. (A) Membranes from strain DJ211-5-3 were resolved on
Renografin density gradients, and the fractions were assayed for
plasma membrane ATPase (O) and an integral membrane subunit of
the vacuolar H+ ATPase (0). Densities of the fractions are indicated
by the dashed line. (B) Strain DJ211-5-3 was treated with cyclohexi-
mide 5 min before the addition of a-factor at time zero. At the times
indicated, membranes were resolved on Renografin gradients and the
fractions were analyzed for a-factor receptor by using antibodies
directed to the carboxy terminus. The amount of receptor is the
percentage found in each fraction. Exposure to a-factor was for 0 min
(0), 8 min (0), and 20 min (E). (C) The percentage of receptor
molecules found in the plasma membrane peak (fractions 7 to 12) and
the percentage of receptors found in the vacuolar peak (fractions 1 to
6) are plotted as a function of the duration of a-factor exposure.
Receptor found in the plasma membrane peak: *, culture that
ioo
,100 S
0.
(I)
-4- 50
0
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time (min)
FIG. 2. Turnover of a-factor receptors. Strains DJ211-5-3 (PEP4)
and DJ900-A (pep4::URA3) were treated with cycloheximide 5 min
before the addition of a-factor at time zero. Shown is a time course
depicting the decay of receptor protein for strain DJ211-5-3 that had
been incubated in the presence (-) and in the absence (0) of a-factor.
No significant decay was observed for strain DJ900-A incubated in the
presence (R) or in the absence (O) of pheromone.
this 8-min period (Fig. 2). Hence, 8 min is an accurate estimate
for the median transit time between the plasma membrane and
the internal compartments. This value obtained at 30°C agrees
with our previous determination of 10 min for the half-life of
cell-surface a-factor binding sites at 34°C (30).
Degradation of a-factor receptors is dependent on vacuolar
proteases. The shift in density of the membranes carrying
a-factor receptors following pheromone treatment indicates
that the receptors exit the plasma membrane. Although these
internalized receptors colocalized with a vacuolar marker
protein, an unequivocal assignment of the vacuole as the final
destination cannot be made by using these data, as other
internal cellular membranes also migrate to this position in the
Renografin gradients. As a criterion for determining whether
the internalized receptors are directed to the vacuole, we asked
whether receptor degradation was stimulated by a-factor and
whether this degradation was dependent on the proteolytic
activities that reside in the vacuole. Since the product of the
PEP4 gene is required for the processing of vacuolar proteases,
vacuoles in pep4 mutants are almost completely devoid of
proteolytic activities (31). Thus, the exposure of a protein to
the vacuolar lumen is suggested by differences in its turnover
rates in PEP4+ and pep4 strains.
Figure 2 shows the effect of al-factor on receptor turnover
in a wild-type strain that expresses the normal complement
of vacuolar proteases and in a pep4 mutant that lacks the
activities of the major vacuolar proteases. Cells were treated
with cycloheximide to block new receptor synthesis, and the
subsequent decay of receptor protein was monitored. In the
PEP4+ strain, the half-life of the receptor was approximately
35 min, whereas in a parallel culture that received a-factor, the
half-life was reduced to 20 min. In contrast, when the same
measurements were made with an isogenic pep4 mutant, we
found that the receptors were stable over the entire length of
the 90-min time course, regardless of ax-factor treatment. Davis
et al. (19) have reported a similar PEP4 dependence on the
received ax-factor; O, untreated control. Receptor found in the vacu-
olar peak: *, culture that received oa-factor; 0, untreated control.
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FIG. 3. Membrane fractionation and localization of a-factor recep-
tors in strain DJ900-A (pep4::URA3). The culture was treated with
cycloheximide 5 min before the addition of a-factor at time zero. After
0 min (0), 8 min (0), and 20 min (O) of a-factor exposure, the
membranes were resolved by Renografin density gradient centrifuga-
tion as for Fig. 1B, and the fractions were assayed for a-factor receptor
protein by using antibodies directed to its carboxy-terminal domain.
turnover rate of the a-factor receptor in the absence of
pheromone. Our results indicate that a.-factor stimulates the
movement of the receptors to the vacuole, where they are
degraded in a PEP4-dependent manner. The degradation of
the receptors in the absence of pheromone presumably reflects
basal protein turnover, which also occurs in the vacuole. Since
the accumulation of receptors in the vacuole was not detect-
able in the absence of a-factor (Fig. 1B), the rate-determining
step in receptor turnover is apparently delivery to the vacuole
rather than degradation of material that has reached the
vacuole. In contrast, since a vacuolar pool of receptors accu-
mulates in the presence of a-factor, it appears that the faster
internalization rate causes degradation in the vacuole to
become rate limiting.
Renografin density gradient centrifugation was used to
ensure that the stability of the receptors in thepep4 mutant was
not a consequence of failure to exit the plasma membrane.
Figure 3 shows that the majority of receptors are present in the
plasma membrane fractions in the absence of a-factor and that
they appear in the vacuolar fractions after the cells have been
exposed to a-factor. However, a number of differences can be
noted in comparing the gradient profile of the pep4 mutant
(Fig. 3) with that of the PEP4+ strain (Fig. 1B), even though
the localization of the marker proteins is not affected by the
pep4 mutation (data not shown). Before a-factor treatment, a
significant proportion of receptor in the pep4 strain was found
in fraction 5, a fraction that contains a portion of the vacuolar
marker protein (Fig. 1A). We expected some of the receptor to
be initially present in the vacuole in the pep4 mutant, since the
receptors that would have migrated to the vacuole as part of
the basal receptor turnover would fail to be degraded in this
protease-deficient strain. With increasing time after phero-
mone addition, the receptor left the plasma membrane peak
and shifted to fraction 5 and eventually appeared in fraction 2,
illustrating that the receptors in thepep4 mutant are capable of
exiting the plasma membrane. Whether the material in fraction
5 represents a transport intermediate is unclear, since the
vacuolar marker protein Vphl is found in a broad peak
spanning fractions 1 through 7 (Fig. 1A).
Proteolytic cleavage of cell surface receptors. Further evi-
dence supporting the exit of receptors from the plasma mem-
brane in response to ax-factor was obtained by examining the
susceptibility of receptors to extracellular proteases. Under the
appropriate conditions, the receptors present at the cell sur-
face are expected to be cleaved by exogenously added pro-
tease, while the internal receptors remain protected from
proteolysis. Optimal assay conditions were sought by exposing
intact cells to a number of different proteases under a variety
of digestion conditions. Following electrophoretic analysis of
whole-cell extracts, antibodies specific for the carboxy-terminal
cytoplasmic domain of the receptor were used to detect intact
receptors as well as the proteolytic fragments generated by
cleavages in the exposed amino-terminal extension and in the
extracellular loops of the receptor. Antibodies to phosphoglyc-
erate kinase (PGK) were used to monitor proteolysis of
cytoplasmic proteins. Trypsin digestion proved to be unsuit-
able, as it gave insufficient cleavage of the receptor whereas
pronase and proteinase K, even though they cleaved the
receptor efficiently, were also unsuitable since they resulted in
nonspecific degradation of other cellular proteins as evidenced
by the proteolysis of PGK and by a general loss of high-
molecular-weight proteins on Coomassie blue-stained gels
(data not shown). Chymotrypsin was chosen for our assay as it
gave nearly complete cleavage of the receptor without affecting
the levels of intact PGK (Fig. 4) or bulk protein (not shown).
The cycloheximide that was added to the cultures to prevent
new protein synthesis, however, appeared to inhibit the action
of chymotrypsin, since a slightly reduced extent of receptor
cleavage was observed for the cultures that had been treated
with cycloheximide (compare lane 8 in Fig. 4A with lane 8 in
Fig. 4B). Moreover, cultures treated with cycloheximide for a
longer duration showed a greater reduction in chymotrypsin
susceptibility (not shown). For this reason, the results depicted
in Fig. 4A were obtained with multiple identical cultures in
which the addition of ax-factor was staggered so that the period
of cycloheximide exposure would remain constant for each of
the time points.
As depicted in Fig. 4, pheromone receptors showed a
reduced susceptibility to proteolytic cleavage when the cultures
were exposed to a-factor. Cells of thepep4 strain that had been
exposed to oa-factor for various lengths of time were poisoned
with NaN3 and KF to prevent further internalization of the
receptor and then treated with chymotrypsin to cleave the
receptors at the cell surface. The intact receptor species were
defined as the forms that were present in controls that did not
receive chymotrypsin-full-length receptors are known to be
glycosylated and give multiple electrophoretic bands (5, 34).
The proteolyzed species were defined as the forms that were
present only in the reaction mixtures that contained chymotryp-
sin. Nearly all of the receptors were susceptible to chymotrypsin at
early times after al-factor addition, since the majority of the
immunoreactive material was recovered as proteolytic fragments
ranging in size from 20 to 30 kDa, corresponding to cleavage in
the extracellular loops. With increasing duration of a-factor
exposure, recovery of the proteolytic fragments decreased as
recovery of the intact receptor molecules increased, consistent
with the receptors leaving the cell surface and moving to an
internal compartment where they were protected from prote-
olysis. By 20 min, essentially all of the receptor protein was
recovered as the intact, protected species.
The rate at which the cell surface receptors were protected
from proteolysis was the same for the cells that had been
cultured in the presence (Fig. 4A) or in the absence (Fig. 4B)
of cycloheximide. Thus, it appears that the loss of protease
sensitivity is not a result of cycloheximide treatment, nor are
the kinetics of acquired resistance to chymotrypsin altered by
cycloheximide treatment. Moreover, the rate of appearance of
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FIG. 4. Sensitivity of a-factor receptors to exogenous protease.
Strain DJ900-A (pep4::URA3) was exposed to ax-factor for the duration
indicated in the presence (A) or absence (B) of cycloheximide. Cells
were poisoned with NaN3 and KF and then subjected to chymotrypsin
digestion (+) or mock protease treatment (-). Proteolytic products of
the receptor were resolved electrophoretically and detected with
antibodies directed to the intracellular carboxy-terminal domain. The
positions of the intact forms and the proteolyzed forms of the receptor
are indicated at the left and molecular mass markers (in kilodaltons)
are shown at the right of each panel. To monitor nonspecific proteol-
ysis of cytoplasmic proteins, the immunoblots were reprobed with
antibodies directed to the cytoplasmic protein PGK (bottom of each
panel).
chymotrypsin-resistant receptors mirrors the rate at which
receptors were removed from the plasma membrane as deter-
mined by Renografin density gradient centrifugation (Fig. 1C).
However, minor differences between the cycloheximide-
treated and untreated cultures were observed. As mentioned
above, cycloheximide reduced the efficiency of receptor cleav-
age that was apparent in the samples from shorter periods of
ax-factor exposure, since more of the receptor remained intact
in the presence of cycloheximide even though the majority of
these receptors were at the cell surface (Fig. 3). In the absence
of cycloheximide, the persistence of some chymotrysin-sensi-
tive receptors after the longest ax-factor exposures was antici-
pated because of the continued synthesis of new receptors in
the absence of cycloheximide. For the cycloheximide-treated
cultures, a-factor exposure also reduced the recovery of recep-
tors in the samples that did not receive chymotrypsin during
the control incubation (Fig. 4A, first seven lanes). This twofold
loss is likely to be a consequence of slow degradation of
intracellular receptors by the endogenous proteolytic activities
present even in a pep4 strain, since there was no loss of
FIG. 5. Membrane fractionation and localization of truncated re-
ceptors during a-factor treatment. Strain DJ903-C (MATa ste2-T326
mfod.::URA3) was treated with cycloheximide 5 min before the addi-
tion of ox-factor at time zero. After 0 min (0), 8 min (@), and 20 min
(l) of ox-factor exposure, the membranes were resolved by Renografin
density gradient centrifugation as for Fig. 1B, and the fractions were
assayed for ox-factor receptor protein by using antibodies directed to its
amino-terminal domain.
receptors in the pep4 strain when this second incubation was
omitted (Fig. 2). In the absence of cycloheximide, this reduc-
tion in receptor level was probably offset by the increased rate
of receptor synthesis that is induced by a-factor (25, 30).
Internalization defects of truncated ai-factor receptors. The
carboxy-terminal cytoplasmic domains of many cell surface
receptors have been shown to contain sequences necessary for
receptor internalization (59). The carboxy-terminal cytoplas-
mic domain of the ax-factor receptor appears to consist of 133
amino acids. Truncation mutants that remove part or all of this
domain lead to a(-factor hypersensitivity and a failure to
recover from a-factor exposure (34, 47). The role of this
domain in receptor down regulation and pheromone internal-
ization has been explored in several laboratories (34, 47, 49).
To look directly at the ability of truncated receptors to leave
the plasma membrane in response to pheromone, we em-
ployed our membrane fractionation and chymotrypsin suscep-
tibility assays. The truncation allele ste2-T326 was analyzed in
this study for the purpose of clarifying conflicting reports in the
literature concerning the capacity of these mutant receptors to
undergo ligand-stimulated internalization (34, 49). Cells car-
rying MATa barl ste2-T326 are supersensitive to pheromone
because of the receptor truncation (34) and because of the
barl mutation, which blocks at-factor degradation (13, 56).
Thus, many of these cells in culture are large and distended,
presumably because they respond to the low level of at-factor
produced by the a cells that have switched mating type. We
found that the A'ITa barl ste2-T326 mfotl::URA3 strain used
in our receptor internalization assays did not exhibit this
phenotype, consistent with the MFotl gene being the major
source of a-factor in aL cells (36).
The MATa barl ste2-T326 mfotl::URA3 strain was subjected
to the Renografin density gradient centrifugation analysis
described in the legend to Fig. 1. As shown in Fig. 5, the
truncated receptors failed to leave the plasma membrane peak,
even after a 20-min exposure to pheromone. The presence of
the mfotl::URA3 allele did not affect the endocytosis of wild-
type receptors or the position of the marker proteins within the
gradient (data not shown). As further evidence for the failure
A.
proteolyzed
PGK --- _ - I'.
5 10
fraction number
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of the truncated receptors to leave the plasma membrane in
response to a-factor, we looked at the susceptibility of the
truncated receptors to chymotrypsin cleavage (not shown). In
this test, cells were exposed to pheromone and then treated
with chymotrypsin as described in the legend to Fig. 4, except
that antiserum directed against the amino-terminal domain of
the receptor was used for the Western blot (immunoblot)
analysis. We found that none of the receptors was protected
from chymotrypsin degradation even after a 20-min exposure
to a-factor; however, the use of the amino terminus-specific
antibodies precluded the detection of the proteolytic frag-
ments generated by cleavage of cell surface receptors.
These data support the view that the truncated receptors fail
to exit the plasma membrane in response to pheromone. This
is consistent with the inabilities of these truncated receptors to
internalize pheromone and to undergo down regulation (49).
The ability of the truncated receptor sites to undergo ax-factor-
induced down regulation in the earlier reports (34) was
apparently due to blockage of the cell surface binding sites by
the initial a-factor exposure, since longer washing periods
following ax-factor treatment revealed that the receptor sites
were not lost from the cell surface (49, and unpublished data).
Although the truncated receptors show a normal affinity for
a-factor (34, 47), the rates of association and dissociation of
the ligand are reduced significantly (46, and unpublished data).
These observations underscore the importance of using a
direct assay for the internalization of receptor protein, since
irreversible association of a-factor with its cell surface receptor
sites can result in the down regulation of cell surface receptor
sites and apparent a-factor internalization.
a-Factor-induced internalization of receptors defective for
pheromone response. The results of the preceding section and
other published reports (47, 49) suggest that the intracellular
factors controlling receptor internalization recognize struc-
tural features of the receptor contained in its carboxy-terminal
cytoplasmic domain. Apparently, different structural features
are recognized during the signal transduction events that lead
to the arrest of cell division and the transcriptional induction of
pheromone-responsive genes. In order to determine whether
the structural features that specify signal transduction also
participate in receptor internalization, we wished to examine
the internalization properties of receptor mutants that block
pheromone-induced transcription and cell division arrest. By
using in vitro mutagenesis of the entire STE2 gene, we
obtained mutation ste2-L236H, which encoded receptors that
retained normal pheromone-binding activity and yet failed to
arrest cell division in response to a-factor. This substitution of
histidine for leucine in the third cytoplasmic loop of the
receptor was also isolated by Weiner et al. (61) after exhaustive
PCR mutagenesis of the sequence encoding the third intracel-
lular loop. Weiner et al. (61) found that this mutant receptor is
partially defective for G protein coupling in that at-factor
affinity is only marginally influenced by the binding of nucle-
otides to the G protein. The mutant cells require six times
more a-factor to give comparable transcriptional induction of
a pheromone-responsive gene (FUS1-lacZ) and four times
more a-factor to give a comparable zone of growth inhibition
in an at-factor halo assay. We found a comparable fivefold
reduction in at-factor sensitivity for the mutant in the halo
assay, but the ability of the mutant to induce the synthesis of
cell surface agglutinins was reduced by 100-fold (50% effective
concentration = 2 x 108 M a-factor for the mutant versus 2
x 10`0 M for the wild-type control). As shown in Fig. 6, the
mutant cells arrest division and recover from the effects of 1 x
10-7 M ax-factor in a manner that is indistinguishable from
wild-type cells that had been exposed to 2.5 x 10-' M; hence,
70
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FIG. 6. Pheromone response of the ste2-L236H signalling-defective
mutant. Strain DJ211-5-3 (STE2) and strain DJ901-A-1 (ste2-L236H)
were cultured with various concentrations of a-factor. The percentage
of unbudded cells in these cultures is plotted as a function of the
duration of a-factor exposure. (A) Strain DJ211-5-3 (STE2) received 1
x 10" M (@), 5 x 10-9 M (0), 2.5 x 10-9 M (-), 1 x 10-9 M ([),
or 5 x 10-1 M a-factor (A) or no pheromone (A). (B) Strain
DJ901-A-1 (ste2-L236H) received i0' M (O) or 108 M (0) a-factor
or no pheromone (A).
this behavior of the mutant also indicates a weaker response to
a-factor.
The pheromone response defect of the ste2-L236H mutant
does not block its ability to internalize a-factor (61). We
wished to determine directly whether the ste2-L236H mutant
blocks the ability of a-factor receptors to exit the plasma
membrane and move to an internal compartment. The
Renografin density gradient fractionation technique was used
to examine movement of the ste2-L236H mutant receptors in
response to at-factor. With increasing duration of a-factor
exposure, the mutant receptors shifted from the plasma mem-
brane fractions to a position of lesser buoyant density in the
gradient (Fig. 7). A similar shift was observed for the wild-type
receptors (Fig. 1B). The rate of this process is also very similar
to the wild-type case. Thus, the ste2-L236H mutation, which
decreases pheromone responsiveness, has no detectable effect
on the internalization of receptors.
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FIG. 7. Membrane fractionation of cells expressing signalling-de-
fective receptors. Strain DJ901-A-1 (ste2-L236H) was treated with
cycloheximide and presented with a-factor at time zero. After 0 min
(0), 8 min (0), and 20 min (C1) of ax-factor exposure, the membranes
were resolved by Renografin density gradient centrifugation as for Fig.
iB, and the fractions were assayed for oL-factor receptor protein by
using antibodies directed to its carboxy-terminal domain.
DISCUSSION
We report the first direct evidence for ligand-stimulated
internalization of the at-factor receptor, and we have tested
whether specific mutant receptors are internalized in response
to ligand. Previous evidence supporting internalization was
indirect in that it was based on the down regulation of cell
surface binding sites that accompanied pheromone internaliza-
tion (14, 30). Although these results provided preliminary
evidence for ligand-mediated endocytosis of the at-factor re-
ceptor, this interpretation was limited by the possibility that the
receptors were inactivated by at-factor binding or that at-factor
bound irreversibly to receptor sites that remained at the cell
surface. Indeed, we have found that the down regulation of
surface receptor sites observed for truncated forms of the
receptor (34, 47) appears to be a consequence of stable binding
of ao-factor to the receptor sites rather than ligand-mediated
endocytosis. We report methods that directly measure the
ligand-induced removal of the ao-factor receptor from the
plasma membrane. The membrane fractionation studies
showed that the receptors exited the plasma membrane when
the cells had been exposed to pheromone and that these
receptors could be recovered in fractions of lighter buoyant
density containing vacuolar membrane proteins. Moreover,
at-factor exposure led to a sequestered form of the receptor
that was no longer susceptible to cleavage by chymotrypsin.
Davis et al. (19) have recently reported that the basal turnover
of a(-factor receptors is dependent on the activity of vacuolar
proteases. We find that receptor turnover is stimulated by
ao-factor exposure and that the more rapid turnover rate is also
dependent on vacuolar protease activity. Thus, it appears that
the final destination for both occupied and unoccupied recep-
tors is the vacuole. Whether basal and ligand-induced endocy-
toses follow the same pathway from the plasma membrane to
the vacuole is not known.
The kinetics at which CL-factor receptors exited the plasma
membrane allowed us to estimate the time required for the
receptors to be translocated from the plasma membrane to the
internal compartments of the cell. For cells that had been
growing in the absence of ao-factor, all of the receptors were
found in the plasma membrane fractions and were susceptible
to chymotrypsin cleavage in whole cells. We were able to
follow the fate of these receptors after a-factor addition, since
the synthesis of new receptors had been blocked with cyclo-
heximide. After 8 min, half of the receptors had left the cell
surface. Since the half-life of total receptor protein was 20 min
in the presence of a-factor and since receptors accumulated in
the vacuolar fractions during this period, we concluded that the
clearance of receptors in the presence of a-factor was limited
by the rate of their degradation in the vacuole. Our inability to
detect receptors in vacuolar fractions in the absence of pher-
omone suggests that the basal rate of turnover is limited by exit
from the plasma membrane. Therefore, the presence of pher-
omone stimulates the removal of the receptors from the
plasma membrane, perhaps by altering the conformation of the
receptor so that it is more efficiently recognized by the
endocytic machinery of the cell. The presence of cycloheximide
in these experiments did not appear to affect the initial kinetics
of receptor movement, since identical results were obtained for
the early time points when cycloheximide was omitted. Previ-
ous studies also showed that cycloheximide had no effect on
the initial rate at which receptor binding sites disappeared
from the cell surface (30).
The characteristics of ao-factor receptor internalization re-
ported here are similar to those reported by Singer and
Riezman for the internalization of a-factor pheromone (54).
Half of the pheromone is internalized after 4 min at 30°C (54).
Singer and Riezman used Nycodenz density gradients to show
that pheromone internalized for 20 min at 15°C was resolved
into two peaks corresponding to buoyant densities of 1.12 and
1.14 g/ml (54). After 20 min at 30°C, we found the receptor in
a similar range of 1.09 to 1.15 g/ml in Renografin gradients.
The association of the internalized at-factor with two different
membrane fractions may represent intermediates in the endo-
cytic pathway such as early and late endosomes (55) or possibly
the vacuolar compartment. Whether the pheromone and the
receptor remain in a stable complex as they are translocated
through the pathway is not known; however, it is clear that
both reach the same final destination, as the degradation of the
pheromone, as well as the receptor, is dependent on vacuolar
proteases (54).
Our findings concerning the internalization of the a-factor
receptor are similar to recent reports (19, 58) concerning
a-factor receptor internalization. Turnover of a-factor recep-
tors is dependent on vacuolar proteases (half-life = 20 min at
30°C in the absence of pheromone) (19). In the presence of
a-factor, receptors were found to move into a protease-
resistant compartment within 60 min at 30°C (19). Further
protease susceptibility studies of the a-factor receptor that
were conducted at 37°C showed that the half-life for receptor
internalization was between 11 and 15 min (58), a range that is
similar to that observed for the a-factor receptor at 30°C.
Immunofluorescence studies using cells overexpressing the
a-factor receptor provided evidence supporting the movement
of receptors from the plasma membrane to the vacuole;
however, because the vacuole contained a significant number
of receptors before the cells had been exposed to pheromone,
it is unclear whether additional receptors were delivered to the
vacuole or were simply lost from the cell surface. Davis et al.
(19) also reported the isolation of a trans-acting mutation,
renl-l (allelic to vps2), that affects receptor internalization.
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This mutation also blocks the turnover of both pheromone
receptors, thereby suggesting that a common mechanism is
used for the endocytosis of both receptors. These authors also
found that mutation renl-l blocked the ligand-induced as well
as the basal turnover of truncated a-factor receptors (19),
suggesting that the basal and the ligand-induced endocytic
pathways also share common steps. Even though an intracel-
lular compartment is the major site of a-factor receptor
accumulation in the renl-l mutant, the overall rate at which
receptors are lost from the cell surface is reduced. This raises
the possibility that endocytosed receptors recycle from this
intermediate compartment to the cell surface (19). Our results
with the a-factor receptor do not address the issue of receptor
recycling. The overall rate at which a-factor receptors are lost
from the plasma membrane may be a composite of the rates of
internalization and recycling.
The endocytic signal carried by cell surface receptors is
commonly contained in the cytoplasmic, carboxy-terminal tail.
The cytoplasmic tail of the a-factor receptor is thought to
include residues 298 through 431 of the polypeptide backbone(8, 10, 43). Conflicting reports regarding the role of this
domain in endocytosis have been based on indirect assays that
measure the abilities of truncated receptors to promote a-fac-
tor internalization and to undergo ligand-stimulated down
regulation of the cell surface at-factor binding sites. Reneke et
al. (47) found that truncation at position 296 blocked down
regulation, whereas truncation at position 313 resulted in a
reduced capacity for down regulation. Konopka et al. (34)
found that truncation at position 326 blocked the basal rate at
which surface receptor sites were lost but failed to block
ligand-stimulated down regulation of the sites. In contrast,
Rohrer et al. (49) found that a truncation at this position
completely blocked down regulation. Further studies of the
dissociation rates for bound a-factor conducted under the
same assay conditions used in the down regulation assays (30)
reveal that the k0ff rate is reduced 3-fold for the ste2-T326
mutant (our unpublished results) and 3- to 10-fold for internal
deletions of the carboxy-terminal domain (46), even though
the Kd values are unaffected (34, 47). Thus, the standard
indirect assays for endocytosis do not reliably measure recep-
tor internalization because they depend on the dissociation of
a-factor bound to cell surface receptors. The direct assays
reported here indicate that receptors truncated at position 326
remain at the plasma membrane after a-factor exposure, in
agreement with the down regulation and a-factor internaliza-
tion assays of Rohrer et al. (49).
By making point mutations and small internal deletions in
the cytoplasmic tail of the a-factor receptor, Rohrer et al. (49)
determined that the peptide sequence DAKSS spanning resi-
dues 335 to 339 is required for pheromone internalization and
receptor down regulation. Thus, cellular factors that regulate
receptor internalization require, at least in part, this portion of
the cytoplasmic tail. Truncated receptors are found in greater
numbers on the cell surface (34, 47), presumably because of
their reduced basal turnover (34). Hence, the endocytic signal
or signals found in the carboxy-terminal tail of the a-factor
receptor appear to control both basal and ligand-induced
internalization. The a-factor receptor also appears to carry an
internalization signal in its cytoplasmic tail, but this signal is
probably required only for basal receptor turnover (19). Dele-
tion of the final 105 amino acid residues of the a-factor
receptor (truncation at position 365, leaving a 79-residue
cytoplasmic tail) results in receptors that show increased
stability in the absence of a-factor but that remain subject to
ligand-induced endocytosis. A consensus endocytic sequence,
DXKXS, as defined by Rohrer et al. (49), spans residues 397 to
401 and thus is eliminated by truncation at position 365. In the
case of the a-factor receptors, this presumptive endocytic
signal is apparently required only for constitutive endocytosis.
Perhaps a second endocytic signal, one that is eliminated in the
ste2-T326 mutant but not in the ste3-T365 mutant, is required
for ligand-induced internalization.
Binding of a-factor to its receptor initiates the signal trans-
duction events controlling pheromone response in addition to
its role in promoting receptor endocytosis. As a consequence
of its association with pheromone, the receptor is likely to
assume one or more conformational states that allow intracel-
lular factors to recognize the ligand-occupied state. Two types
of information suggest that the factors responsible for receptor
internalization differ from the factors controlling signal trans-
duction. First, trans-acting mutations that alter signal transduc-
tion do not affect receptor-mediated endocytosis, and other
trans-acting mutations that block endocytosis do not affect
signal transduction. Second, truncated receptors are specifi-
cally defective for endocytosis, whereas amino acid substitu-
tions in the third cytoplasmic loop of the receptor are specif-
ically defective for signal transduction. Transacting mutations
in the END3, END4, and REN1 genes block a-factor internal-
ization, yet these mutations do not affect mating or signal
transduction (19, 45). Similarly, mutations in the actin gene
ACT1, the clathrin heavy chain gene CHC1, and the gene for
the yeast fimbrin homolog, SAC6, lead to defects in phero-
mone internalization but have little effect on signal transduc-
tion (35, 48). Furthermore, an intact signal transduction path-
way is not required for receptor endocytosis. Mutations in the
STE4 gene, encoding the a subunit of the heterotrimeric G
protein, or in the STE5 gene block signal transduction events
but have no effect on the down regulation of the receptor (30,
63), whereas mutations in the GPAJ gene, encoding the G
protein a subunit, cause constitutive activation of pheromone
response without affecting the ability of receptors to undergo
down regulation (4). Pheromone receptors expressed from a
plasmid under the control of the GAL promoter in diploid cells
were competent for endocytosis, even though diploid cells do
not have a functional pheromone response pathway (19, 63).
To test whether signal transduction plays a role in the
endocytosis of the receptor, we examined the capacity of
ste2-L236H mutant receptors to undergo ligand-induced endo-
cytosis. Weiner et al. (61), who originally identified this
mutation, showed that it blocks the ability of the receptor to
couple with the G protein in cell-free extracts, that it partially
blocks the ability of cells to respond to a-factor, and that it
does not block a-factor internalization as judged by the stable
association of a-factor with metabolically active cells. Our
results show that this coupling-deficient receptor has a reduced
capacity to mediate cellular responses to a-factor, yet it is able
to undergo ligand-induced endocytosis, in agreement with the
a-factor internalization results of Weiner et al. (61). The
weaker G protein-mediated response observed for this mutant
is anticipated from the analysis of hybrid adrenergic receptors
in which the third cytoplasmic loop of the receptor was found
to specify G protein interaction (22). Taken together, the
results with the ste2-L236H mutant and the truncation mutants
indicate that different structural features of the receptor
specify its interaction with the endocytic and signal transduc-
tion pathways.
Although the ste2-L236H mutant cells show reduced respon-
siveness to a-factor, it is difficult to establish whether this
defect reflects a reduced capacity to generate the initial signal
or an increased sensitivity to the regulatory processes that
dampen the signal. Since the length of time required for cells
to recover from a-factor is proportional to the a-factor con-
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7254 SCHANDEL AND JENNESS
centration used (41), mutant cells that generate a weaker
signal are expected to recover more rapidly. a-Factor halo
assays are often used as a qualitative measure for adaptation,
since the cells within the zone of growth inhibition that
surrounds a source of ao-factor eventually grow to fill the zone.
Weiner et al. (61) propose that the ste2-L236H mutant recep-
tors promote an adaptation pathway, since halo assays of the
mutant initially give a clear zone that fills in more rapidly than
the wild-type control and since the sst2 mutation, which blocks
adaptation (12, 20), also blocks the ability of the ste2-L236H
mutant to fill the zone. In contrast, we believe that the
transient arrest of cell division of the mutant cells within the
zone and the effects of the sst2 mutation could be simple
consequences of a weaker signal in the ste2-L236H mutant and
the profound sensitivity of sst2 mutants to weak signals.
Moreover, after the 2-day incubation period required for this
assay, it is difficult to distinguish the inability to adapt from an
inability to survive prolonged a-factor exposure. The adapta-
tion phenotype of the ste2-L236H mutant could simply result
from the generation of a weaker signal, since our results show
the same arrest and recovery profiles for the mutant cells at
iO-' M ao-factor as for the wild-type cells at 2.5 x 10-9 M
a-factor (Fig. 6). Furthermore, we found zones of ao-factor
inhibition that were turbid and remained turbid throughout the
course of observation when halo assays were conducted with
the mutant cells. Thus, the reduced pheromone responsiveness
of the ste2-L236H mutant is consistent with the generation of
a weaker signal or with an increased ability to adapt to the
signal.
In conclusion, we have examined the ability of this response-
defective mutant to internalize the pheromone receptor. Using
the direct internalization assays described here, we have shown
that cells expressing ste2-L236H are competent for receptor
endocytosis. This provides further evidence that the signals for
receptor internalization and signal transduction are separable
at the level of the receptor, suggesting that different domains
of the receptor participate in these two functions. Different
structural features of the receptor appear to be recognized by
the endocytic machinery and the signal transduction apparatus
within the cell. The carboxy-terminal cytoplasmic tail is re-
quired for the endocytosis of the receptor, while the third
cytoplasmic loop plays a role in signal transduction. However,
we cannot rule out the possibility that some structural features
of the receptor are required for both functions. A more
detailed mutational analysis of the receptor is required to
further define the functional domains of the receptor.
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